Skip to main content
TipRanks
Go Ultimate75% OFF

Bradford Crutchfield Insider Profile

4 Followers

Bradford Crutchfield, former officer at 10x Genomics, holds 97.24K shares in 10x Genomics (Ticker: TXG), holds 5.33K shares in Bio-Rad Laboratories (Ticker: BIO), holds 0.00 shares in NanoString Technologies (Ticker: NSTGQ). Most recently, Bradford Crutchfield Sold ― shares of 10x Genomics on May 25, 2022 for an estimated value of $13.95K.

Bradford Crutchfield's Trading History

TXG
10x Genomics
May 25, 2022former officerInformative Sell13.95K$5.35M
BIO
Bio-Rad Laboratories
Jun 11, 2014EVPUninformative Buy10.98K$1.92M
NSTGQ
NanoString Technologies
―――$0.00

You May Also Like

Bradford Crutchfield insider profile FAQ

What is the percentage of profitable transactions made by Bradford Crutchfield?
The percentage of profitable transactions made by Bradford Crutchfield is 80%.
What is the average return per transaction made by Bradford Crutchfield?
The average return per transaction made by Bradford Crutchfield is 50.30%.
What stocks does Bradford Crutchfield hold?
Bradford Crutchfield holds: TXG, BIO, NSTGQ stocks.
What was Bradford Crutchfield’s latest transaction?
Bradford Crutchfield’s latest transaction was an Informative Sell of $13.95K.
What was Bradford Crutchfield's most profitable transaction?
Bradford Crutchfield’s most profitable transaction was an Informative Sell of TXG stock on August 25, 2021. The return on the trade was 76.80%.
What is Bradford Crutchfield's role in 10x Genomics?
Bradford Crutchfield's role in 10x Genomics is former officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.